Effects of B1 and B2 kinin receptor antagonists in diabetic mice

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 5, 1996, Pages 586-589

  Zuccollo, Adriana ^a   Navarro, Monica ^a   Catanzaro, Orlando ^a  

^a Universidad Nacional del Litoral   (Argentina)

Author keywords

Insulitis; Kinin receptor antagonists; Kinin receptors; Type I diabetes

Indexed keywords

BRADYKININ RECEPTOR; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; KININ; BRADYKININ; BRADYKININ, LEU(8) DES ARG(9); BRADYKININ, LEU(8)-DES-ARG(9)-; DRUG DERIVATIVE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULITIS; KALLIKREIN KININ SYSTEM; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; URINE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BRADYKININ; DIABETES MELLITUS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, BRADYKININ; STREPTOZOCIN;

EID: 85047675723     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-047     Document Type: Article

References (12)

1. Catanzaro, O.L., Marina Prendes, M.G., Hope, S., Zuccollo, A., and Dominguez, A. 1994. Streptozotocin-induced hyperglycemia is decreased by nitric oxide inhibition. Braz. J. Med. Biol. Res. 27: 2043-2047.
2. Cooke, A. 1990. An overview on possible mechanisms of destruction of the insulin-producing B cells. Curr. Top. Microbiol. Immunol. 164: 125-142.
3. Davis, A.J., and Perkins, M. 1994. The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol. 113: 63-68.
4. Dray, A., and Perkins, M. 1993. Bradykinin and inflammatory pain. Trends Neurosci. 16: 99-104.
5. 15N] nitrite in biological fluids. Anal. Biochem. 126: 131-138.
6. Griesbacher, T., and Lembeck, F. 1992. Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br. J. Pharmacol. 107: 356-360.
7. Hall, J.M. 1992. Bradykinin receptors. Pharmacological properties and biological roles. Pharmacol. Ther. 56: 131-190.
8. Harvey, J.N., Edmundson, A.W., and Mayfield, R.K. 1990. Renal kallikrein in IDDM patients with glomerular hyperfiltration. Diabetes, 39: 72A.
9. Kolb-Bachofen, V., Epstein, S., Kiesel, J., and Kolb, H. 1988. Low dose streptozotocin-induced diabetes in mice. Electron microscopy reveals single cell insulitis before diabetes onset. Diabetes, 37: 21-27.
10. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.
11. Mandrup-Poulsen, T., Bendtzen, K., Nielsen, J.H., Bendixen, G., and Nerup, J. 1985. Cytokines cause functional and structure damage to isolated islets of Langerhans. Allergy, 40: 424-490.
12. Vila, S.B., Peluffo, V., Alvarado, C., Cresto, J.C., Zuccollo, A., and Catanzaro, O.L. 1992. The kallikrein kinin system in early state of diabetes. Agents Actions, 38(III): 304-310.